Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence

International Journal of Infectious Diseases

Volumn 16, Issue 2, 2012, Pages

  Guardia, Ana Carolina ^a   Stucchi, Raquel Silveira Bello ^a   Sampaio, Ana Maria ^a   Milan, Arlete ^a   Costa, Sandra Cecília Botelho ^a   Pavan, Célia Regina ^a   Boin, Ilka de Fátima Santana Ferreira ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytomegalovirus; Hepatitis; Human herpesvirus 6; Liver transplantation

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RECURRENT INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOPSY; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84856000072     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.10.008     Document Type: Article

References (52)

1. Kusne S., Blair J.E. Viral and fungal infections after liver transplantation-part II. Liver Transpl 2006, 12:2-11.
2. Singh N., Wannstedt C., Keyes L., Wagener M.M., de Vera M., Cacciarelli T.V., et al. Impact of evolving trends in recipients and donor characteristics on cytomegalovirus infection in liver transplant recipients. Transplantation 2004, 77:106-110.
3. Lautenschlager I., Lappalainen M., Linnavuori K., Suni J., Höckerstedt K. CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. J Clin Virol 2002, 25(Suppl 2):S57-S61.
4. Helanterä I., Loginov R., Koskinen P., Lautenschlager I. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection. Transpl Int 2008, 21:980-984.
5. Cervera C., Marcos M.A., Linares L., Roig E., Benito N., Pumarola T., et al. A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients. Transplantation 2006, 82:979-982.
6. Yamanishi K. Human herpesvirus 6 and human herpesvirus 7. Fields virology 2001, 2785-2801. Lippincott Williams and Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley, B.E. Griffin, R.A. Lamb, M.A. Martin, S.E. Roizman, Straus (Eds.).
7. Razonable R.R., Brown R.A., Humar A., Covington E., Alecock E., Paya C.V., et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 2005, 192:1331-1339.
8. Sampaio A.M., Thomasini R.L., Guardia A.C., Stucchi R.S., Rossi C.L., Costa S.C., et al. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia. Transplant Proc 2011, 43:1357-1359.
9. Ljungman P., Griffiths P., Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097.
10. Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Snydman D.R., et al. Transplantation Society International CMV Consensus Group. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010, 89:779-795.
11. Razonable R.R., Emery V.C. Management of CMV infection and disease in transplant patients. Herpes 2004, 11:77-86.
12. Razonable R.R., Paya C.V. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 2003, 10:60-65.
13. Razonable R.R., Lautenschlager I. Impact of human herpes virus 6 in liver transplantation. World J Hepatol 2010, 2:345-353.
14. Razonable R.R., Zerr D.M. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. AST Infectious Diseases Community of Practice. Am J Transplant 2009, 4:97-100.
15. Bizollon T., Ducerf C., Trepo C., Mutimer D. Hepatitis C virus recurrence after liver transplantation. Gut 1999, 44:575-578.
16. Burak K.W., Kremers W.K., Batts K.P., Wiesner R.H., Rosen C.B., Razonable R.R., et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002, 8:362-369.
17. Humar A., Kumar D., Raboud J., Caliendo A.M., Moussa G., Levy G., et al. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant 2002, 2:461-466.
18. Razonable R.R., Burak K.W., van Cruijsen H., Brown R.A., Charlton M.R., Smith T.F., et al. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis 2002, 35:974-981.
19. Singh N., Husain S., Carrigan D.R., Knox K.K., Weck K.E., Wagener M.M., et al. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002, 16:92-96.
20. Boeckh M., Nichols W.G. Immunosuppressive effects of beta-herpesviruses. Herpes 2003, 10:12-16.
21. El-Serag H.B., Anand B., Richardson P., Rabeneck L. Association between hepatitis C infection and other infectious diseases: a case for targeted screening?. Am J Gastroenterol 2003, 98:167-174.
22. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
23. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 199;114:282-4.
24. Gayowski T., Singh N., Marino I.R., Vargas H., Wagener M., Wannstedt C., et al. Hepatitis C virus genotypes in liver transplant recipients: impact on post-transplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997, 64:422-426.
25. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheur P.J. Classifi{ligature}cation of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
26. Shibata D., Martin W.J., Appleman M.D., Causey D.M., Leedom J.M., Arnheim N. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis 1988, 158:1185-1192.
27. Demmler G.J., Buffone G.J., Schimbor C.M., May R.A. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988, 158:1177-1184.
28. Secchiero P., Carrigan D.R., Asano Y., Benedetti L., Crowley R.W., Komaroff A.L., et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995, 171:273-280.
29. Aquino V.H., Figueiredo L.T. Cytomegalovirus infection in renal transplant recipients diagnosed by nested-PCR. Braz J Med Biol Res 2001, 34:93-101.
30. Costa F.A., Soki M.N., Andrade P.D., Bonon S.H., Thomasini R.L., Sampaio A.M., et al. Simultaneous monitoring of CMV and human herpesvirus 6 infections and diseases in liver transplant patients: one-year follow-up. Clinics (Sao Paulo) 2011, 66:949-953.
31. Milan A., Sampaio A.M., Guardia A.C., Pavan C.R., Andrade P.D., Bonon S.H., et al. Monitoring and detection of cytomegalovirus in liver transplant recipients. Transplant Proc 2011, 43:1360-1361.
32. Abdel Massih R.C., Razonable R.R. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol 2009, 15:2561-2569.
33. Thomasini R.L., Sampaio A.M., Bonon S.H., Boin I.F., Leonardi L.S., Leonardi M., et al. Detection and monitoring of human herpesvirus 7 in adult liver transplant patients: impact on clinical course and association with cytomegalovirus. Transplant Proc 2007, 39:1537-1539.
34. Krueger G.R., Klueppenberg U., Hoffman A., Ablashi D.V. Clinical correlates of infection with human herpesvirus-6. In Vivo 1994, 8:457-516.
35. Costa S.C. Infecção por citomegalovirus (CMV); epidemiologia, diagnóstico e tratamento. Rev Bras Clín Ter 1999, 25:18-28.
36. De Bolle L., Naesens L., De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005, 18:217-245.
37. Boin I.D., Boteon Y.L., Stucchi R.S., Pereira M.I., Portugal T.C., Udo E.Y. Serological profile of pretransplantation liver patients. Transplant Proc 2010, 42:491-493.
38. Sebeková K., Feber J., Carpenter B., Shaw L., Karnauchow T., Diaz-Mitoma F., et al. Tissue viral DNA is associated with chronic allograft nephropathy. Pediatr Transplant 2005, 9:598-603.
39. Ward K.N., Leong H.N., Nacheva E.P., Howard J., Atkinson C.E., Davies N.W., et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 2006, 44:1571-1574.
40. Härmä M., Höckerstedt K., Krogerus L., Lautenschlager I. Pretransplant human herpesvirus 6 infection of patients with acute liver failure is a risk factor for posttransplant human herpesvirus 6 infection of the liver. Transplantation 2006, 81:367-372.
41. Coates P.J., d'Ardenne A.J., Khan G., Kangro H.O., Slavin G. Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax section. J Clin Pathol 1991, 44:115-118.
42. Greer C.E., Lund J.K., Manos M.M. PCR amplification from paraffin-embedded tissues: recommendations on fixatives for long-term storage and prospective studies. PCR Methods Appl 1991, 1:46-50.
43. Arthurs S.K., Eid A.J., Pedersen R.A., Kremers W.K., Cosio F.G., Patel R., et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl 2007, 13:1703-1709.
44. Paya C., Humar A., Dominguez E., Washburn K., Blumberg E., Alexander B., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004, 4:611-620.
45. Fitzgerald J.T., Gallay B., Taranto S.E., McVicar J.P., Troppmann C., Chen X., et al. Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival. Transplantation 2004, 77:1405-1411.
46. Härmä M., Höckerstedt K., Lyytikäinen O., Lautenschlager I. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation. J Med Virol 2006, 78:800-805.
47. Razonable R.R., Paya C.V. Infections and allograft rejection-intertwined complications of organ transplantation. Swiss Med Wkly 2005, 135:571-573.
48. Griffiths P.D., Ait-Khaled M., Bearcroft C.P., Clark D.A., Quaglia A., Davies S.E., et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999, 59:496-501.
49. Wiesner R.H., Sorrell M., Villamil F. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 2003, 9:1-9.
50. Rosen H.R., Chou S., Corless C.L., Gretch D.R., Flora K.D., Boudousquie A., et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997, 64:721-726.
51. Humar A., Washburn K., Freeman R., Paya C.V., Mouas H., Alecock E., et al. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl 2007, 13:1422-1427.
52. Lee S.O., Brown R.A., Razonable R.R. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation 2011, 92:224-229.